» Articles » PMID: 34631471

Management of Biliary Atresia: To Transplant or Not to Transplant

Overview
Specialty General Surgery
Date 2021 Oct 11
PMID 34631471
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Kasai procedure (KP) and liver transplantation (LT) represent the only therapeutic options for patients with biliary atresia (BA), the most common indication for LT in the pediatric population. However, KP represents by no means a radical option but rather a bridging one, as nearly all patients will finally require a liver graft. More and more experts in the field of transplant surgery propose that maybe it is time for a paradigm change in BA treatment and abandon KP as transplantation seems inevitable. Inadequacy of organs yet makes this option currently not feasible, so it seems useful to find ways to maximize the efficacy of KP. In previous decades, multiple studies tried to identify these factors which opt for better results, but in general, outcomes of KP have not improved to the level that was anticipated. This review provides the framework of conditions which favor native liver survival after KP and the ones which optimize a positive LT outcome. Strategies of transition of care at the right time are also presented, as transplantation plays a key role in the surgical treatment of BA. Future studies and further organization in the transplant field will allow for greater organ availability and better outcomes to be achieved for BA patients.

Citing Articles

The Assessment and Management of Biliary Atresia in Hawai'i, 2009-2023.

Singh S, Balaraman K, Johnson M, Balaraman V, Puapong D, Johnson S Hawaii J Health Soc Welf. 2024; 83(10):268-273.

PMID: 39371585 PMC: 11450321. DOI: 10.62547/NUOX8943.


Diseases of bile duct in children.

Eiamkulbutr S, Tubjareon C, Sanpavat A, Phewplung T, Srisan N, Sintusek P World J Gastroenterol. 2024; 30(9):1043-1072.

PMID: 38577180 PMC: 10989494. DOI: 10.3748/wjg.v30.i9.1043.


Editorial: Elimination of biliary atresia.

Kotb M, Ieiri S, Shehata S Front Pediatr. 2023; 11:1202727.

PMID: 37284287 PMC: 10241068. DOI: 10.3389/fped.2023.1202727.

References
1.
Shneider B, Brown M, Haber B, Whitington P, Schwarz K, Squires R . A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006; 148(4):467-474. DOI: 10.1016/j.jpeds.2005.12.054. View

2.
Altman R, Lilly J, Greenfeld J, Weinberg A, Van Leeuwen K, Flanigan L . A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg. 1997; 226(3):348-53; discussion 353-5. PMC: 1191037. DOI: 10.1097/00000658-199709000-00014. View

3.
Chen Y, Nah S, Chiang L, Krishnaswamy G, Low Y . Postoperative steroid therapy for biliary atresia: Systematic review and meta-analysis. J Pediatr Surg. 2015; 50(9):1590-4. DOI: 10.1016/j.jpedsurg.2015.05.016. View

4.
Bezerra J, Spino C, Magee J, Shneider B, Rosenthal P, Wang K . Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014; 311(17):1750-9. PMC: 4303045. DOI: 10.1001/jama.2014.2623. View

5.
Mack C, Sokol R . Unraveling the pathogenesis and etiology of biliary atresia. Pediatr Res. 2005; 57(5 Pt 2):87R-94R. DOI: 10.1203/01.PDR.0000159569.57354.47. View